Create Medic Co., Ltd. (JP:5187)
:5187
Top Page
Create Medic Co., Ltd.
(5187)
Select Model
Select Model
Rating:72Outperform
Price Target:
¥1,244.00
▲(19.96% Upside)
Action:ReiteratedDate:02/18/26
The score is driven primarily by solid financial stability (strong balance sheet and steady revenue growth) but held back by inconsistent profitability and weaker, lumpy cash generation. Technicals are supportive with an established uptrend, and valuation is helped by a reasonable P/E and a ~4% dividend yield.
Positive Factors
Conservative balance sheet / low leverage
Low reported leverage (debt roughly 5% of equity) gives the company durable financial flexibility to fund R&D, manage working capital through procedure cycles, and support capex or dividends without relying on volatile external financing, lowering insolvency risk.
Negative Factors
Volatile profitability and earnings quality
Marked swings in net income and uneven operating profit growth point to inconsistent cost control or non-recurring impacts. Persistent profitability volatility reduces the quality of reported earnings, complicates forecasting and capital allocation, and limits sustainable return generation.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet / low leverage
Low reported leverage (debt roughly 5% of equity) gives the company durable financial flexibility to fund R&D, manage working capital through procedure cycles, and support capex or dividends without relying on volatile external financing, lowering insolvency risk.
Read all positive factors
Create Medic Co., Ltd. (5187) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥10.57B
Dividend Yield3.52%
Average Volume (3M)7.98K
Price to Earnings (P/E)44.3
Beta (1Y)0.26
Revenue Growth4.97%
EPS Growth-10.07%
CountryJP
Employees1,002
SectorHealthcare
Sector Strength45
IndustryMedical - Devices
Share Statistics
EPS (TTM)5.80
Shares Outstanding9,664,327
10 Day Avg. Volume3,800
30 Day Avg. Volume7,980
Financial Highlights & Ratios
PEG Ratio-1.05
Price to Book (P/B)0.53
Price to Sales (P/S)0.64
P/FCF Ratio88.32
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Create Medic Co., Ltd. Business Overview & Revenue Model
Company Description
Create Medic Co., Ltd. researches, develops, manufactures, and sells medical appliances in Japan and internationally. The company offers disposable medical devices made of silicone resin. It provides various urology, gastroenterology, percutaneous...
How the Company Makes Money
Create Medic Co., Ltd. generates revenue primarily through the sale of its medical devices and healthcare solutions. The company operates a multi-faceted revenue model that includes direct sales to healthcare providers, partnerships with distribut...
Create Medic Co., Ltd. Financial Statement Overview
Summary
Income Statement
64
Positive
Balance Sheet
83
Very Positive
Cash Flow
52
Neutral
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.29B | 13.62B | 13.03B | 12.59B | 12.33B | 11.70B |
| Gross Profit | 5.93B | 5.99B | 5.70B | 5.48B | 5.37B | 5.26B |
| EBITDA | 1.49B | 1.58B | 1.73B | 1.50B | 1.47B | 1.43B |
| Net Income | 703.04M | 713.73M | 840.90M | 154.02M | 482.21M | 660.41M |
Balance Sheet | ||||||
| Total Assets | 18.23B | 20.14B | 20.05B | 19.26B | 19.12B | 18.08B |
| Cash, Cash Equivalents and Short-Term Investments | 4.71B | 5.83B | 6.32B | 4.39B | 4.31B | 4.36B |
| Total Debt | 42.96M | 749.70M | 891.96M | 884.78M | 933.42M | 815.36M |
| Total Liabilities | 2.93B | 3.81B | 4.30B | 4.31B | 4.40B | 3.86B |
| Stockholders Equity | 15.31B | 16.33B | 15.75B | 14.94B | 14.72B | 14.22B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 98.51M | 1.77B | 246.98M | 101.75M | 629.58M |
| Operating Cash Flow | 0.00 | 530.12M | 2.25B | 698.84M | 461.34M | 1.25B |
| Investing Cash Flow | 0.00 | -573.08M | 270.62M | -363.61M | 38.01M | -585.01M |
| Financing Cash Flow | 0.00 | -600.39M | -877.65M | -362.19M | -355.59M | -442.52M |
Create Medic Co., Ltd. Technical Analysis
Positive
1037.00
Price Trends
1148.98
Positive
1083.78
Positive
1024.65
Positive
Market Momentum
-2.04
Negative
53.80
Neutral
75.25
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:5187, the sentiment is Positive. The current price of 1037 is below the 20-day moving average (MA) of 1148.20, below the 50-day MA of 1148.98, and above the 200-day MA of 1024.65, indicating a bullish trend. The MACD of -2.04 indicates Negative momentum. The RSI at 53.80 is Neutral, neither overbought nor oversold. The STOCH value of 75.25 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:5187.
Create Medic Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥19.86B | 15.12 | ― | 3.02% | -4.36% | -14.92% | |
72 Outperform | ¥10.57B | 44.27 | ― | 3.52% | 4.97% | -10.07% | |
68 Neutral | ¥106.49B | 26.70 | ― | 2.31% | 4.36% | 79.43% | |
65 Neutral | ¥250.91B | 36.37 | ― | 1.92% | 4.31% | 96.31% | |
63 Neutral | ¥14.75B | 14.76 | ― | 3.12% | 3.59% | -163.08% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | ¥141.80B | 28.05 | 2.42% | 3.73% | 0.04% | ― |
* Healthcare Sector Average
JP:5187
Create Medic Co., Ltd.
1,162.00
269.62
30.21%
JP:6523
PHC Holdings Corp.
1,119.00
157.97
16.44%
JP:4549
Eiken Chemical Co., Ltd.
3,230.00
1,033.21
47.03%
JP:6678
Techno Medica Co., Ltd.
2,330.00
612.24
35.64%
JP:6849
Nihon Kohden Corporation
1,503.00
-421.66
-21.91%
JP:7600
Japan Medical Dynamic Marketing, Inc.
560.00
10.62
1.93%
Create Medic Co., Ltd. Corporate Events
Create Medic Lifts Dividend as Profit Mix Shifts on Solid 2025 Sales
Feb 13, 2026
Create Medic Co., Ltd., a Tokyo Standard-listed medical device manufacturer focused on hospital-use products, reported steady top-line growth for the year ended December 31, 2025, with net sales rising 4.5% to ¥13.6 billion. Operating profit ...
Create Medic Lifts Dividend as Profits Rebound on Higher Sales
Feb 13, 2026
Create Medic reported a 4.5% rise in net sales to ¥13.62 billion for the year ended December 31, 2025, with operating profit surging 45.1% and ordinary profit up 31.7%, although profit attributable to owners fell 15.1% due partly to a lower s...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.